Alicia Hong focuses her practice on China-related corporate transactions in the life sciences industry. She advises on cross-border mergers and acquisitions, licensing, co-development, strategic alliances, VC or PE investment and public listings, as well as joint venture, technology transfer and other collaboration projects.
Alicia has over 15 years of extensive experience in facilitating transactions between European, US and Asian companies, thanks to her knowledge of Chinese pharma and biotech industry landscape, the IP and regulatory development, as well as extended network of contacts in China including international pharma or biotech companies, PE and VC funds, state-owned enterprises and domestic private companies.
Prior to joining McDermott, Alicia has worked for other international law firms in both Shanghai and Frankfurt.
Represented Vaximm AG in its outlicensing and investment agreement with a major Chinese pharmaceutical company
Represented Mologen AG, a German public company in its licensing and co-development agreement with a well-known VC backed US-China biotech company for Mologen’s Phase III asset in the oncology space.
Represented a Canada-based biotech company, Resverlogix, in a license and equity investment transaction with a Chinese publicly listed company Shenzhen Hepalink Pharmaceutical Co. for Resverlogix’s RVX-208 program*
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.